Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cardiovascular Ultrasound|January 15, 2020
Prognostic value of point-of-care ultrasound during cardiac arrest: a systematic reviewIlan Kedan, William Ciozda, Joseph A Palatinus, et al.
Journal of the American Association of Nurse Practitioners|November 6, 2024
Integration of point-of-care ultrasound in a nurse practitioner-led heart failure clinicChristina Light Craigo, Theresa Brown, Ilan Kedan, et al.
Cardiovascular Ultrasound|August 21, 2016
The efficacy of sonographic measurement of inferior vena cava diameter as an estimate of central venous pressureWilliam Ciozda, Ilan Kedan, Devin W Kehl, et al.
JMIR Research Protocols|March 22, 2017
Implementation of a Home Monitoring System for Heart Failure Patients: A Feasibility StudyMartin Steven Kohn, Jeffrey Haggard, Jack Kreindler, et al.
The American Journal of Cardiology|April 27, 2017
Usefulness of Serial Measurements of Inferior Vena Cava Diameter by Vscan<sup>TM</sup> to Identify Patients With Heart Failure at High Risk of HospitalizationRaj M Khandwalla, Kade T Birkeland, Raymond Zimmer, et al.
Ethnicity & Disease|September 28, 2011
Acute myocardial infarction quality of care: the Strong Heart StudyLyle G Best, Amir Butt, Britt Conroy, et al.
Journal of Cardiac Failure|December 15, 2022
Postdischarge Noninvasive Telemonitoring and Nurse Telephone Coaching Improve Outcomes in Heart Failure Patients With High Burden of ComorbidityAsher Kimchi, Harriet U Aronow, Yu-Ming Ni, et al.
The International Journal of Cardiovascular Imaging|January 4, 2021
Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumabJie Sun, Norman E Lepor, Gádor Cantón, et al.
Atherosclerosis|May 26, 2021
Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course studyNorman E Lepor, Jie Sun, Gador Canton, et al.
JMIR Research Protocols|December 22, 2017
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover TrialKade Birkeland, Raj M Khandwalla, Ilan Kedan, et al.
Pageof 2